Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This randomized, multicenter, placebo-controlled, double-blind study will evaluate the
efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing
motor response fluctuations (OFF phenomena) as an outpatient (i.e., at home) and in the
clinic.
Patients who successfully complete this study will be eligible to enroll into a 12 month
treatment extension (CVT-301-004E) study.